Related content

Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice

By Kudo Masatoshi  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 242-255

Springer Publishing Company

Access to resources Recommend Favorite

Molecularly targeted therapy for hepatocellular carcinoma from the basic and clinical aspects

By Arii Shigeki  

International Journal of Clinical Oncology, Vol. 15, Iss. 3, 2010-06 ,pp. : 234-234

Springer Publishing Company

Access to resources Recommend Favorite

Basic science going clinical: molecularly targeted therapy of chronic myelogenous leukemia

By Deininger Michael  

Journal of Cancer Research and Clinical Oncology, Vol. 130, Iss. 2, 2004-02 ,pp. : 59-72

Springer Publishing Company

Access to resources Recommend Favorite

EpCAM-Targeted Therapy for Human Hepatocellular Carcinoma

By Ogawa Kousuke   Tanaka Shinji   Matsumura Satoshi   Murakata Ayano   Ban Daisuke   Ochiai Takanori   Irie Takumi   Kudo Atsushi   Nakamura Noriaki   Tanabe Minoru   Arii Shigeki  

Annals of Surgical Oncology, Vol. 21, Iss. 4, 2014-04 ,pp. : 1314-1322

Springer Publishing Company

Access to resources Recommend Favorite

Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy

By Thomas Melanie  

Annals of Surgical Oncology, Vol. 15, Iss. 4, 2008-04 ,pp. : 1008-1014

Springer Publishing Company

Access to resources Recommend Favorite